Advertisement

Topics

Companies Related to "Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)" [Most Relevant Company Matches] RSS

22:19 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)" found in our extensive corporate database of over 50,000 company records.

Showing "Study Describe Risk Bleeding Patients Depending Different Anticoagulant" Companies 1–25 of 5,200+

Relevant

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.


The Comprehensive Bleeding Disorders Center (CBDC)

The Comprehensive Bleeding Disorders Center (CBDC) was incorporated in 1996 as a nonprofit organization, established specifically to serve people with congenital bleeding disorders. Osvaldo H. Wesly, MD, serves as the Medical Director for CBDC. It is the only federally-funded center in Illinois outside of Chicago providing and supporting comprehensive services to persons with bleeding and clotting...

Stop the Bleeding Coalition

The mission of the Stop the Bleeding Coalition is to show how quick access to life-saving, easy-to-use Bleeding Control Kits can save lives. Whether law enforcement, a layperson, or teacher in a school, one can administer immediate simple medical care to victims that stops hemorrhage with Bleeding Control Kits. The goals of SBC are to educate how immediate...


Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

ProFibrix B.V.

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a unique dry powder topical tissue sealant in development to stop bleeding after or during surgery. Fibrocaps is clearly differentiated from existing liquid tissue sealants and hemostats: it is ready for immediate use, is stable at room temperature, and has shown to be safe and efficacious...

Biolife, LLC

Biolife, L.L.C. is a privately-owned company that manufactures and distributes a patented topical powder that stops bleeding and forms a seal over an external bleeding wound or an access site.

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

PLC Systems Inc.

PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

SENES Oak Ridge, Inc.,

SENES Oak Ridge, Inc., Center for Risk Analysis, founded in 1992, is committed to attaining the highest level of technical excellence and transparency in all its work. SENES Oak Ridge specializes in human health and ecological risk estimation, risk assessment, and risk communication.SENES offers comprehensive, multidisciplinary consulting services in areas related to human health and ecological ri...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Accumetrics

Accumetrics develops, manufactures, and markets the VerifyNow™ System, a comprehensive system for the assessment of platelet function. Modulation of platelet function plays a critical role in effectively treating cardiovascular, cerebrovascular, and peripheral vascular disease. VerifyNow is the only rapid platelet function test shown to correlate with clinical outcomes. The tests provide doctors...

Priska

Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessment consists of a 5-question survey and fits each patient into one of three risk categories: low risk, moderate risk or high risk. The peer-reviewed tool is highly trusted and wid...

Saranas

Saranas is a privately held Houston, Texas-based medical device company focused on improving patient outcomes through early detection of internal bleeding complications. The company’s patented introducer sheath technology for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediat...

Northwestern Internists, Ltd.

We would like to take a few minutes of your time to describe our practice and familiarize you with our philosophy, office procedures, and patient services. Please feel free to contact us at the office if you have additional questions or you would like to schedule an appointment.We are a group practice of physicians, board-certified in general internal medicine. All of our members have hospital p...

Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...

ARYx Therapeutics, Inc.

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered products designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of these original ...

United Health Products, Inc.

United Health Products, Inc. (formerly United EcoEnergy Corp.) is a healthcare solutions company that has developed an innovative hemostatic gauze product that stops bleeding by forming into a gel-like substance upon contact with blood. The gauze was initially developed as a tool to provide medical professionals the ability to stop bleeding in the most eff...

Vitrolife AB (publ)

The fourth of the total of twelve patients included in the USA study for STEEN Solution™, and which enables sales approval in the important USA market, has now received a transplant. The first transplantation was carried out in September and four transplantations have thus now been carried out at four centres. A fifth centre, Duke University, has been ...

Alydia Health

Alydia Health is a medical device company dedicated to making childbirth safer for all mothers. The device concept was developed in 2010 at Cal Poly in an effort to design a global solution for postpartum hemorrhage. With a goal of encouraging natural physiologic recovery, the device is designed to work with the normal contractions of the uterus to rapidly ...

Saranas, Inc.

Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The company’s patented bleed monitoring system for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immed...

Saranas Inc.

Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The company’s patented bleed monitoring system for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immed...


More From BioPortfolio on "Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks